Neuraxis, INC
Neuraxis, INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 8 | 7 | 5 | 4 | 6 | 2 | 4 | 0 | 2 | 0 | 0 | 1 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 9 | 8 | 6 | 5 | 7 | 3 | 4 | 1 | 2 | 0 | 0 | 1 | |||||
Property Plant And Equipment Gross | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Depreciation Depletion And Amortizatio… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | |||||||||||||||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Security Deposit | - | - | 0 | - | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Assets | 10 | 9 | 6 | 6 | 7 | 3 | 5 | 1 | 3 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Notes Payable To Bank Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 5 | 1 | - | - | |||||
Notes Payable Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Deposits | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 8 | 4 | 2 | 2 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Liabilities Noncurrent | - | - | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 4 | 2 | 2 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 76 | 72 | 68 | 65 | 65 | 59 | 59 | 54 | 48 | 47 | 47 | 42 | |||||
Retained Earnings Accumulated Deficit | -70 | -66 | -65 | -63 | -61 | -59 | -57 | -55 | -54 | -51 | -49 | -43 | |||||
Stockholders Equity | 7 | 6 | 3 | 2 | 4 | 0 | 2 | -2 | -5 | -3 | -1 | -1 | |||||
Liabilities And Stockholders Equity | 10 | 9 | 6 | 6 | 7 | 3 | 5 | 1 | 3 | 1 | 1 | 1 | |||||
Unamortized Debt Issuance Expense | - | - | - | - | - | - | - | - | 0 | 0 | - | - | |||||
Allowance For Doubtful Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.001 | - | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Inventory Raw Materials Net Of Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | 1 | - | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | - | - | - | - | 4 | 4 | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | - | - | - | - | 4 | 4 | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 12 | 11 | 11 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | |||||
Shares Outstanding | 12 | 11 | 11 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.29% | -14.63% | -24.06% | - | - | - | - | - | - | - | - | - |
| 2025 | 12.50% | 11.21% | 7.76% | -2.41% | 27.71% | 9.24% | 4.30% | 74.22% | 65.23% | -4.47% | 14.53% | -4.47% |
| 2024 | 0.00% | -1.01% | 4.71% | -1.67% | 1.93% | -5.14% | -14.87% | -23.42% | -20.89% | -21.15% | -11.89% | 14.98% |
| 2023 | - | - | - | -10.45% | -23.88% | -16.42% | -11.54% | 2.78% | 6.84% | 3.61% | -4.38% | -10.46% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.04 | 2.89 | 2.05 | 1.58 | 2.82 | 1.21 | 1.75 | 0.24 | 0.28 | 0.11 | 0.13 | 0.43 | |||||
| Quick Ratio | 2.83 | 2.65 | 1.85 | 1.43 | 2.61 | 1.07 | 1.62 | 0.12 | 0.25 | 0.05 | 0.08 | 0.40 | |||||
| Working Capital | 6.32M | 5.33M | 2.94M | 1.84M | 4.27M | 439.82K | 1.83M | -2.03M | -5.48M | -3.41M | -1.64M | -1.29M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.48 | 0.52 | 0.88 | 1.53 | 0.67 | 10.72 | 1.30 | -1.64 | -1.50 | -1.30 | -1.36 | -2.16 | |||||
| Interest Coverage TTM | -73.67 | -74.30 | -105.85 | -158.81 | -86.18 | -50.80 | -41.05 | -23.40 | -24.64 | -16.89 | - | - | |||||
| Debt Ratio | 0.33 | 0.34 | 0.47 | 0.60 | 0.40 | 0.91 | 0.57 | 2.57 | 3.00 | 4.37 | 3.75 | 1.86 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.62 | 0.73 | 0.64 | 0.97 | 0.66 | 1.48 | 1.02 | 2.74 | 1.47 | 3.28 | - | - | |||||
| Days Sales Outstanding TTM | 19.27 | 26.80 | 22.51 | 8.74 | 15.63 | 20.78 | 21.59 | 10.35 | 22.83 | 10.64 | - | - | |||||
| Receivables Turnover TTM | 18.94 | 13.62 | 16.21 | 41.74 | 23.35 | 17.56 | 16.90 | 35.26 | 15.99 | 34.32 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.65 | -0.68 | -0.86 | -0.78 | -0.84 | -1.13 | -1.19 | -1.47 | -2.52 | -2.56 | - | - | |||||
| Free Cash Flow Per Share TTM | -0.50 | -0.56 | -0.71 | -0.47 | -0.55 | -0.86 | -0.89 | -0.98 | -1.22 | -1.23 | - | - | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 85.56% | 85.01% | 84.23% | 84.00% | 84.47% | 85.47% | 86.52% | 87.31% | 87.50% | 87.82% | - | - | |||||
| Operating Profit Margin TTM | -144.51% | -169.93% | -219.37% | -225.43% | -221.62% | -259.62% | -266.46% | -251.89% | -312.02% | -273.49% | - | - | |||||
| Net Profit Margin TTM | -148.00% | -174.53% | -218.55% | -230.15% | -222.91% | -286.19% | -306.84% | -323.77% | -567.33% | -539.07% | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 65.22% | 45.88% | 32.89% | 3.10% | 4.73% | -5.53% | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | 9.70% | -11.03% | -5.35% | -26.71% | -58.85% | -49.85% | - | - | - | - | - | - | |||||
| EPS Growth (1Y) | -22.88% | -39.35% | -27.90% | -46.79% | -66.58% | -55.98% | - | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -11.26 | -10.84 | -5.29 | -3.93 | -2.87 | -1.91 | -1.97 | -2.02 | -1.10 | -1.22 | - | - | |||||
| P/B TTM | 13.15 | 14.10 | 12.13 | 13.32 | 4.85 | 62.08 | 7.86 | -11.91 | -3.66 | -6.42 | -6.19 | -12.98 | |||||
| P/S TTM | 16.67 | 18.92 | 11.55 | 9.05 | 6.41 | 5.47 | 6.05 | 6.55 | 6.26 | 6.58 | - | - | |||||
| Market Cap | 88.60M | 81.02M | 41.24M | 30.42M | 20.62M | 16.05M | 16.26M | 21.37M | 19.24M | 20.44M | 8.68M | 13.78M | |||||
| Enterprise Value | 80.32M | 74.04M | 36.42M | 26.05M | 14.63M | 14.04M | 12.72M | 21.11M | 22.20M | 21.66M | 8.61M | 13.02M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -6.02M | -6.09M | -6.49M | -4.68M | -4.65M | -6.40M | -6.13M | -7.01M | -8.44M | -8.07M | - | - | |||||
| Net Debt | -8.28M | -6.98M | -4.82M | -4.38M | -5.99M | -2.01M | -3.54M | -260.89K | 2.96M | 1.22M | -78.56K | -761.25K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Neuraxis, INC (NRXS) — SEC Financial Statements & Analysis
Neuraxis, INC (NRXS) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Neuraxis, INC trades on NYSE as: NRXS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Neuraxis, INC reported a 65.22% year-over-year revenue growth, a Gross Profit Margin of 85.56% (TTM), a Debt-to-Equity ratio of 0.48x, a Price-to-Sales (P/S) ratio of 16.67x (TTM), a Price-to-Book (P/B) ratio of 13.15x (TTM), at a market cap of $88.60M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 65.22%
- Gross Profit Margin TTM
- 85.56%
- Debt To Equity
- 0.48x
- P/S TTM
- 16.67x
- P/B TTM
- 13.15x
- Market Cap
- $88.60M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Neuraxis, INC in?
Neuraxis, INC (NRXS) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What is NRXS's market cap?
Neuraxis, INC (NRXS) has a market capitalization of $88.60M as of 2026-06-30.
What exchange does NRXS trade on?
Neuraxis, INC (NRXS) trades on the NYSE.
Where is Neuraxis, INC incorporated?
Neuraxis, INC is incorporated in DE.